TP53 and neoplasm: The authors argue that sustained activation of p53 after chronic DEN treatment leads to increased hepatocyte apoptosis and subsequent induction of a strong inflammatory response mediated by high-mobility group box 1 (HMGB1) release, which favors tumor development by attracting immune cells or stimulating neighboring cells to release pro-inflammatory cytokines [128].